Diagnosing diseases is basically the frontlines when it comes to fighting against illnesses and how effectively and efficiently this is done will affect how the rest of the battle goes. Unfortunately, diagnosis can be expensive, depending on the disease. Thanks to a new microchip, which can cost only $0.1 to create, this might not be a problem anymore.
The microchip in question was created by a team of engineers from Stanford who published their findings in the Proceedings of the National Academy of Sciences. Not only is the chip tiny, it’s also incredibly inexpensive to produce and can be manufactured at a large scale in a very short period of time.
“For the developing world, point-of-care (POC) diagnostics design must account for limited funds, modest public health infrastructure, and low power availability,” the paper reads. “To address these challenges, here we integrate microfluidics, electronics, and inkjet printing to build an ultra–low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.”
Calling it the FNIP chip, the researchers created the device with three layers of varying expendability. As for how it is used, it’s basically a two-step process. First, the user would need to customize the configuration in order to suit the particular disease that needs to be diagnosed, Futurism reports. Next, the necessary samples for analysis can then be printed onto the top layer of the chip.
So, which diseases can this microchip detect? So far, the researchers tested it to analyze cancer fluid and succeeded. They also used it to diagnose immune cells and was able to pull off similar results as another diagnostic tool that would have cost $100,000 in comparison.
Before anyone gets too excited, however, the researchers are saying that it would take some time before the microchip becomes widely available. There are some hurdles to overcome first, including more tests to see if the platform is even safe to use.


RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
OpenAI's $34B Spending Pushes AI Market Leadership Ahead of IPO
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
The four types of dementia most people don’t know exist
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs
Why the future of marijuana legalization remains hazy despite high public support
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 



